Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes.

Tapia G, Mortimer G, Ye J, Gillard BT, Chipper-Keating S, Mårild K, Viken MK, Lie BA, Joner G, Skrivarhaug T, Njølstad PR, Størdal K, Gillespie KM, Stene LC.

Pediatr Diabetes. 2019 Sep;20(6):728-735. doi: 10.1111/pedi.12875. Epub 2019 Jun 19.

PMID:
31173445
2.

The novel HLA-A*01 variant, HLA-A*01:308N, detected by sequencing-based typing.

Hynne AS, Hopland BI, Jensen T, Boulland LML, Viken MK.

HLA. 2019 Sep;94(3):312. doi: 10.1111/tan.13606. Epub 2019 Jun 17.

PMID:
31144452
3.

The novel HLA-A*03 variant, HLA-A*03:08:01:02, detected by sequencing-based typing.

Hopland BI, Andersen SH, Jensen T, Boulland LML, Viken MK.

HLA. 2019 Jul;94(1):60-61. doi: 10.1111/tan.13549. Epub 2019 Apr 26.

PMID:
30977308
4.

Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes.

Tapia G, Mårild K, Dahl SR, Lund-Blix NA, Viken MK, Lie BA, Njølstad PR, Joner G, Skrivarhaug T, Cohen AS, Størdal K, Stene LC.

Diabetes Care. 2019 Apr;42(4):553-559. doi: 10.2337/dc18-2176. Epub 2019 Jan 28.

PMID:
30692241
5.

Prenatal iron exposure and childhood type 1 diabetes.

Størdal K, McArdle HJ, Hayes H, Tapia G, Viken MK, Lund-Blix NA, Haugen M, Joner G, Skrivarhaug T, Mårild K, Njølstad PR, Eggesbø M, Mandal S, Page CM, London SJ, Lie BA, Stene LC.

Sci Rep. 2018 Jun 13;8(1):9067. doi: 10.1038/s41598-018-27391-4.

6.

Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis.

Guderud K, Mæhlen MT, Nordang GBN, Viken MK, Andreassen BK, Molberg Ø, Flåm ST, Lie BA.

J Rheumatol. 2018 Aug;45(9):1211-1219. doi: 10.3899/jrheum.170769. Epub 2018 Jun 1.

PMID:
29858238
7.

HLA -A, -C, -B, -DRB1, -DQB1 and -DPB1 allele and haplotype frequencies in 4514 healthy Norwegians.

Lande A, Andersen I, Egeland T, Lie BA, Viken MK.

Hum Immunol. 2018 Jul;79(7):527-529. doi: 10.1016/j.humimm.2018.04.012. Epub 2018 Apr 21.

PMID:
29684411
8.

Plasma immunological markers in pregnancy and cord blood: A possible link between macrophage chemo-attractants and risk of childhood type 1 diabetes.

Vistnes M, Tapia G, Mårild K, Midttun Ø, Ueland PM, Viken MK, Magnus P, Berg JP, Gillespie KM, Skrivarhaug T, Njølstad PR, Joner G, Størdal K, Stene LC.

Am J Reprod Immunol. 2018 Mar;79(3). doi: 10.1111/aji.12802. Epub 2017 Dec 20.

PMID:
29266506
9.

Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.

Popperud TH, Viken MK, Kerty E, Lie BA.

PLoS One. 2017 Oct 16;12(10):e0186383. doi: 10.1371/journal.pone.0186383. eCollection 2017.

10.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657
11.

Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data.

Dahl J, Refsum E, Ahlen MT, Egeland T, Jensen T, Viken MK, Stuge TB, Acharya G, Husebekk A, Skogen B, Tiller H.

J Reprod Immunol. 2017 Aug;122:1-9. doi: 10.1016/j.jri.2017.06.003. Epub 2017 Jun 27.

PMID:
28686909
12.

HLA class II alleles in Norwegian patients with coexisting type 1 diabetes and celiac disease.

Viken MK, Flåm ST, Skrivarhaug T, Amundsen SS, Sollid LM, Drivvoll AK, Joner G, Dahl-Jørgensen K, Lie BA.

HLA. 2017 May;89(5):278-284. doi: 10.1111/tan.12986. Epub 2017 Feb 28.

PMID:
28247576
13.

Midpregnancy and cord blood immunologic biomarkers, HLA genotype, and pediatric celiac disease.

Mårild K, Vistnes M, Tapia G, Midttun Ø, Ueland PM, Viken MK, Magnus P, Berg JP, Stene LC, Størdal K.

J Allergy Clin Immunol. 2017 May;139(5):1696-1698. doi: 10.1016/j.jaci.2016.10.016. Epub 2016 Nov 16. No abstract available.

PMID:
27865861
14.

Autoimmune risk variants in ERAP2 are associated with gene-expression levels in thymus.

Gabrielsen IS, Viken MK, Amundsen SS, Helgeland H, Holm K, Flåm ST, Lie BA.

Genes Immun. 2016 Dec;17(7):406-411. doi: 10.1038/gene.2016.39. Epub 2016 Nov 10.

PMID:
27829666
15.

A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1.

Bruserud Ø, Oftedal BE, Landegren N, Erichsen MM, Bratland E, Lima K, Jørgensen AP, Myhre AG, Svartberg J, Fougner KJ, Bakke Å, Nedrebø BG, Mella B, Breivik L, Viken MK, Knappskog PM, Marthinussen MC, Løvås K, Kämpe O, Wolff AB, Husebye ES.

J Clin Endocrinol Metab. 2016 Aug;101(8):2975-83. doi: 10.1210/jc.2016-1821. Epub 2016 Jun 2.

16.

Genetic risk variants for autoimmune diseases that influence gene expression in thymus.

Gabrielsen IS, Amundsen SS, Helgeland H, Flåm ST, Hatinoor N, Holm K, Viken MK, Lie BA.

Hum Mol Genet. 2016 Jul 15;25(14):3117-3124. Epub 2016 May 19.

PMID:
27199374
17.

High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.

Liaskou E, Klemsdal Henriksen EK, Holm K, Kaveh F, Hamm D, Fear J, Viken MK, Hov JR, Melum E, Robins H, Olweus J, Karlsen TH, Hirschfield GM.

Hepatology. 2016 May;63(5):1608-19. doi: 10.1002/hep.28116. Epub 2015 Sep 30.

PMID:
26257205
18.

Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases.

Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP, Fleishman SJ, Banka S, Newman WG, Sewell WA, Sozaeva LS, Zayats T, Haugarvoll K, Orlova EM, Haavik J, Johansson S, Knappskog PM, Løvås K, Wolff AS, Abramson J, Husebye ES.

Immunity. 2015 Jun 16;42(6):1185-96. doi: 10.1016/j.immuni.2015.04.021.

19.

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.

Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N.

BMC Cancer. 2014 Nov 19;14:845. doi: 10.1186/1471-2407-14-845.

20.

Resolution of HLA-B*44:02:01G, -DRB1*14:01:01G and -DQB1*03:01:01G reveals a high allelic variability among 12 European populations.

Vidan-Jeras B, Buhler S, Dubois V, Grubic Z, Ivanova M, Jaatinen T, Ligeiro D, Lokki ML, Papasteriades C, Poli F, Spyropoulou-Vlachou M, Tordai A, Viken MK, Wenda S, Nunes JM, Sanchez-Mazas A, Tiercy JM.

Tissue Antigens. 2014 Nov;84(5):459-64. doi: 10.1111/tan.12422. Epub 2014 Sep 11.

PMID:
25209151
21.

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.

Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF.

J Neuroimmunol. 2014 Sep 15;274(1-2):174-9. doi: 10.1016/j.jneuroim.2014.06.024. Epub 2014 Jul 6.

PMID:
25037176
22.

Coeliac disease-associated polymorphisms influence thymic gene expression.

Amundsen SS, Viken MK, Sollid LM, Lie BA.

Genes Immun. 2014 Sep;15(6):355-60. doi: 10.1038/gene.2014.26. Epub 2014 May 29.

PMID:
24871462
23.

Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis.

Maehlen MT, Olsen IC, Andreassen BK, Viken MK, Jiang X, Alfredsson L, Källberg H, Brynedal B, Kurreeman F, Daha N, Toes R, Zhernakova A, Gutierrez-Achury J, de Bakker PI, Martin J, Teruel M, Gonzalez-Gay MA, Rodríguez-Rodríguez L, Balsa A, Uhlig T, Kvien TK, Lie BA.

Ann Rheum Dis. 2015 Apr;74(4):762-8. doi: 10.1136/annrheumdis-2013-204173. Epub 2013 Dec 13.

PMID:
24336335
24.

HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.

Nordang GB, Flåm ST, Maehlen MT, Kvien TK, Viken MK, Lie BA.

Rheumatology (Oxford). 2013 Nov;52(11):1973-82. doi: 10.1093/rheumatology/ket252. Epub 2013 Jul 30.

PMID:
23901134
25.

The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.

Vang T, Landskron J, Viken MK, Oberprieler N, Torgersen KM, Mustelin T, Tasken K, Tautz L, Rickert RC, Lie BA.

Hum Immunol. 2013 May;74(5):574-85. doi: 10.1016/j.humimm.2012.12.017. Epub 2013 Jan 17.

26.

Association analysis of the CCL3L1 copy number locus by paralogue ratio test in Norwegian rheumatoid arthritis patients and healthy controls.

Nordang GB, Carpenter D, Viken MK, Kvien TK, Armour JA, Lie BA.

Genes Immun. 2012 Oct;13(7):579-82. doi: 10.1038/gene.2012.30. Epub 2012 Jul 12.

PMID:
22785612
27.

Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.

Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF.

PLoS One. 2012;7(5):e36603. doi: 10.1371/journal.pone.0036603. Epub 2012 May 9.

28.

Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.

Nordang GB, Viken MK, Amundsen SS, Sanchez ES, Flatø B, Førre OT, Martin J, Kvien TK, Lie BA.

Rheumatology (Oxford). 2012 Apr;51(4):619-26. doi: 10.1093/rheumatology/ker364. Epub 2011 Dec 16.

PMID:
22179739
29.

Evidence for PTPN22 R620W polymorphism as the sole common risk variant for rheumatoid arthritis in the 1p13.2 region.

Martín JE, Alizadeh BZ, González-Gay MA, Balsa A, Pascual-Salcedo D, González-Escribano MF, Rodriguez-Rodriguez L, Fernández-Gutiérrez B, Raya E, Coenen MJ, van Riel P, Radstake TR, Kvien TK, Viken MK, Lie BA, Koeleman BP, Martín J.

J Rheumatol. 2011 Nov;38(11):2290-6. doi: 10.3899/jrheum.110361. Epub 2011 Oct 1.

PMID:
21965649
30.

The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples.

Rodríguez-Rodríguez L, Taib WR, Topless R, Steer S, González-Escribano MF, Balsa A, Pascual-Salcedo D, González-Gay MA, Raya E, Fernandez-Gutierrez B, González-Álvaro I, Bottini N, Witte T, Viken MK, Coenen MJ, van Riel PL, Franke B, den Heijer M, Radstake TR, Wordsworth P, Lie BA, Merriman TR, Martín J.

Arthritis Rheum. 2011 Feb;63(2):365-72. doi: 10.1002/art.30145. Erratum in: Arthritis Rheum. 2011 Mar;63(3):669.

31.

Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.

Mero IL, Ban M, Lorentzen ÅR, Smestad C, Celius EG, Sæther H, Saeedi H, Viken MK, Skinningsrud B, Undlien DE, Aarseth J, Myhr KM, Granum S, Spurkland A, Sawcer S, Compston A, Lie BA, Harbo HF.

Genes Immun. 2011 Apr;12(3):191-8. doi: 10.1038/gene.2010.59. Epub 2010 Dec 23.

PMID:
21179112
32.

Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.

Viken MK, Blomhoff A, Olsson M, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA.

Genes Immun. 2009 Jun;10(4):323-33. doi: 10.1038/gene.2009.13. Epub 2009 Mar 19.

PMID:
19295542
33.

Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand.

Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Førre ØT, Helgetveit K, Kvien TK, Lie BA.

Rheumatology (Oxford). 2009 Apr;48(4):367-70. doi: 10.1093/rheumatology/ken512. Epub 2009 Feb 10.

PMID:
19208686
34.

Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.

Viken MK, Sollid HD, Joner G, Dahl-Jørgensen K, Rønningen KS, Undlien DE, Flatø B, Selvaag AM, Førre Ø, Kvien TK, Thorsby E, Melms A, Tolosa E, Lie BA.

Hum Immunol. 2007 Sep;68(9):748-55. Epub 2007 Jun 28.

PMID:
17869649
35.

The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material.

Viken MK, Olsson M, Flåm ST, Førre O, Kvien TK, Thorsby E, Lie BA.

Tissue Antigens. 2007 Sep;70(3):190-7.

PMID:
17661906
36.

Association analysis in type 1 diabetes of the PRSS16 gene encoding a thymus-specific serine protease.

Lie BA, Viken MK, Akselsen HE, Flåm ST, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE.

Hum Immunol. 2007 Jul;68(7):592-8. Epub 2007 Apr 13.

PMID:
17584581
37.

Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

Lie BA, Viken MK, Odegård S, van der Heijde D, Landewé R, Uhlig T, Kvien TK.

Ann Rheum Dis. 2007 Dec;66(12):1604-9. Epub 2007 May 1.

38.

Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases.

Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V, Sollid LM, Førre OT, Thorsby E, Smerdel A, Lie BA.

Genes Immun. 2005 May;6(3):271-3.

PMID:
15759012
39.

ABI3 mediates expression of the peroxiredoxin antioxidant AtPER1 gene and induction by oxidative stress.

Haslekås C, Grini PE, Nordgard SH, Thorstensen T, Viken MK, Nygaard V, Aalen RB.

Plant Mol Biol. 2003 Oct;53(3):313-26.

PMID:
14750521
40.

Seed 1-cysteine peroxiredoxin antioxidants are not involved in dormancy, but contribute to inhibition of germination during stress.

Haslekås C, Viken MK, Grini PE, Nygaard V, Nordgard SH, Meza TJ, Aalen RB.

Plant Physiol. 2003 Nov;133(3):1148-57. Epub 2003 Oct 2.

Supplemental Content

Loading ...
Support Center